William Garvey
Endocrinology, Diabetes & Metabolism · Birmingham, ALNPI 1114947769
Payments from drug & device makers
Across 3,680 payments — averaging $1030.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$3M
- Eli Lilly$330K
- Novo Nordisk$137K
- F. Hoffmann-la Roche AG$54K
- Boehringer Ingelheim$53K
- Genentech, Inc.$40K
- plus $145K from 23 others
Across 22 payments — averaging $1370.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim International GmbH$27K
- Novo Nordisk AS$3K
- Eli Lilly$644
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 3,319 | $3,033,201 |
| Eli Lilly | 26 | $330,362 |
| Novo Nordisk | 96 | $137,367 |
| F. Hoffmann-la Roche AG | 12 | $54,475 |
| Boehringer Ingelheim | 60 | $52,678 |
| Genentech, Inc. | 17 | $39,716 |
| Sanofi US Services Inc. | 13 | $29,049 |
| Lilly USA, LLC | 5 | $22,097 |
| Regeneron | 35 | $20,851 |
| Pfizer | 12 | $17,725 |
| Merck | 16 | $8,894 |
| Amgen | 11 | $7,616 |
| Zealand Pharma A/s | 7 | $6,510 |
| Neurocrine Biosciences, Inc. | 8 | $5,895 |
| AbbVie | 7 | $5,595 |
| Inogen, Inc. | 2 | $5,144 |
| Corcept Therapeutics | 8 | $4,466 |
| Genentech USA, Inc. | 6 | $3,312 |
| Lexicon Pharmaceuticals, Inc. | 3 | $3,201 |
| Madrigal Pharmaceuticals | 6 | $2,590 |
| Radius Health, Inc. | 1 | $1,225 |
| Janssen Scientific Affairs, LLC | 3 | $389 |
| Dexcom, Inc. | 1 | $158 |
| Sanofi-aventis U.S. LLC | 1 | $126 |
| Abbott | 1 | $124 |
| Bayer | 1 | $115 |
| Valeritas, Inc. | 1 | $106 |
| Johnson & Johnson | 1 | $75 |
| Amarin Pharma, Inc. | 1 | $35 |
How this compares
$3,793,097 in reported general payments places this provider in the 95th percentile of 79 endocrinology, diabetes & metabolism providers in Alabama.
See all endocrinology, diabetes & metabolism providers in Alabama →
Other endocrinology, diabetes & metabolism in Birmingham
- Fernando OvalleBirmingham$516K
- Ralph TeagueBirmingham$487K
- Amy WarrinerBirmingham$182K
- Edison GoncalvesBirmingham$142K
- Fernando BrilBirmingham$74K
- Tom VaughanBirmingham$68K
- Rodrigo ValderramaBirmingham$61K
- Janelle TownesBirmingham$56K
- Richard RosenthalBirmingham$24K
- Ananda BasuBirmingham$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.